Cardiologists Want Concrete Guidance From FDA Panel On Stent Thrombosis
This article was originally published in The Gray Sheet
Executive Summary
Cardiologists are looking to an FDA expert panel meeting this Thursday and Friday for tangible advice about drug-eluting stent use in the face of newly discovered safety risks